share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯维公司 | 144:拟议出售证券
美股SEC公告 ·  08/07 16:27
Moomoo AI 已提取核心信息
Abbvie Inc. officer Hudson Thomas J is set to sell 101,886 shares of the company's common stock, with an aggregate market value of approximately $19,115,379.79. The sale is scheduled for 08/07/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a period where no securities transactions were reported by Hudson in the past three months.
Abbvie Inc. officer Hudson Thomas J is set to sell 101,886 shares of the company's common stock, with an aggregate market value of approximately $19,115,379.79. The sale is scheduled for 08/07/2024, which coincides with the date Hudson acquired the shares through a stock option exercise as part of his compensation from the issuer. This transaction follows a period where no securities transactions were reported by Hudson in the past three months.
AbbVie Inc.职务官员Hudson Thomas J打算卖出101,886股公司普通股,市值约为19,115,379.79美元。该交易计划于2024年08月07日进行,这与Hudson作为补偿计划的一部分行权获得股票的日期相吻合。在过去的三个月中,Hudson没有报告任何证券交易。
AbbVie Inc.职务官员Hudson Thomas J打算卖出101,886股公司普通股,市值约为19,115,379.79美元。该交易计划于2024年08月07日进行,这与Hudson作为补偿计划的一部分行权获得股票的日期相吻合。在过去的三个月中,Hudson没有报告任何证券交易。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息